Previous research showed that Notch4 played a role in maintaining quiescent mesenchymal-like breast cancer stem cells and promoting epithelial-mesenchymal transition in TNBC cells, indicating that Notch4 is a potential therapeutic target for TNBC [14, 15]. This evidence concerns the gene NOTCH4 and breast carcinoma.